Showing results (1931-1940 of 3,444) with videos related to

Sort By:
Pageof 345
Journal of Medicinal Chemistry|December 28, 2021
Chemical Synthesis of Antibody-Hapten Conjugates Capable of Recruiting the Endogenous Antibody to Magnify the Fc Effector Immunity of Antibody for Cancer ImmunotherapyKun Zhou, HaoFei Hong, Han Lin, et al.
Journal of Colloid and Interface Science|January 7, 2022
Thermosensitive and tum or microenvironment activated nanotheranostics for the chemodynamic/photothermal therapy of colorectal tumorShige Wang, Yufan Yang, Hang Wu, et al.
Biomed Research International|October 24, 2022
Motion of Lumbar Endplate in Degenerative Lumbar Scoliosis Patients with Different Cobb Angle In Vivo: Reflecting the Biomechanics of the Lumbar DiscFei Xu, Shuai Jiang, Longjie Wang, et al.
Methods (San Diego, Calif.)|October 25, 2022
MRDFF: A deep forest based framework for CT whole heart segmentationFei Xu, Lingli Lin, Zihan Li, et al.
Therapeutic Advances in Medical Oncology|September 3, 2025
Efficacy and safety of utidelone in pretreated patients with metastatic breast cancer in China: a multicenter, real-world studyShihui Hu, Tengfei Chao, Ning Xie, et al.
Scientific Reports|August 23, 2025
The combined associations of excess body weight, hypertension, and hypertriglyceridemia with hyperglycemia among nondiabetic older adults in regional ChinaXiaojun Ouyang, Liubao Gu, Ting Xu, et al.
Cancer Science|August 23, 2021
LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathwayFei Xu, Qian Hua, Aimi Zhang, et al.
BMC Infectious Diseases|June 17, 2020
The influence of exposure to Toxoplasma Gondii on host lipid metabolismFei Xu, Xiwan Lu, Ruitang Cheng, et al.
Immunotherapy|January 25, 2023
FHL1 as a novel prognostic biomarker and correlation with immune infiltration levels in lung adenocarcinomaJingtao Zhang, Haitao Li, Minghao Guo, et al.
Microorganisms|April 28, 2023
Redistribution and Activation of CD16brightCD56dim NK Cell Subset to Fight against Omicron Subvariant BA.2 after COVID-19 VaccinationHuiyun Peng, Tianxin Xiang, Fei Xu, et al.
Pageof 345